Realising the right to health: access to HIV/AIDS-related medication – Speaking notes to a panel sponsored by UNAIDS, OHCHR and WHO

At least three international developments are worth noting: the outcomes of the UN General Assembly Special Session on HIV/AIDS in June 2001; the establishment of a Global Fund to fight AIDS, Tuberculosis and Malaria; and the Declaration on the TRIPS Agreement and Public Health adopted at the recent 4th WTO Ministerial Conference (Doha, November 2001).

Letter to Prime Minister Jean Chrétien re: Africa and Public Health at the 2002 G8 Summit in Kananaskis

“As humanitarian, human rights, health, labour and development organizations actively engaged in the Canadian and international responses to the global HIV/AIDS pandemic, we wish to commend you on your address to the World Economic Forum on the 1 February 2002 in New York, and on your leadership in support of the objectives outlined within the … Read more

Injection Drug Use, HIV/AIDS, and HCV: Brief to the House of Commons Special Committee on Non-Medical Use of Drugs

The focus of this submission to the House of Commons Special Standing Committee on Non-Medical Use of Drugs is on questions relating to harm reduction and on questions concerning injection drug use in Canada, specifically as they relate to HIV/AIDS. We first discuss the extent to which Canada’s drug laws and policies contribute to the … Read more

Brief to the House of Commons Standing Committee on Justice and Human Rights – Bill C-217 (“Blood Samples Act”)

The Legal Network supports measures to prevent the spread of HIV, including for workers such as police officers, firefighters, and health care workers and good Samaritans. The Legal Network also supports access to quality HIV testing and counselling, and access to care, treatment and support, for those who may be exposed to the risk of … Read more

Letter to Prime Minister and ministers re: Patents and generic drugs in the WTO Ministerial Declaration

“As humanitarian, human rights, and development organisations actively engaged in the Canadian and international responses to the global HIV/AIDS pandemic, we wish to raise with you our grave concerns about current discussions at the World Trade Organisation regarding the Agreement on Trade-Related Aspects of Intellectual Property Rights (“the TRIPS Agreement”), and Canada’s role in those … Read more

Open letter to all members of Parliament re: Patents and generic drugs in the WTO Ministerial Declaration

“As humanitarian, human rights, and development organisations actively engaged in the Canadian and international responses to the global HIV/AIDS pandemic, we wish to raise with you our grave concerns about current discussions at the World Trade Organisation (WTO) regarding the Agreement on Trade-Related Aspects of Intellectual Property Rights (“the TRIPS Agreement”), and Canada’s role in … Read more

Human Rights, Global Responsibility and Access to Treatments in the Developing World – Presentations at 2001 AGM

The 2001 Annual General Meeting of the Canadian HIV/AIDS Legal Network was held in Montréal from Friday, September 21st to Sunday, September 23rd. The AGM opened on the evening of September 21st with a welcome session and a panel discussion on Access to Treatments in Developing Countries. The formal business of the AGM was conducted … Read more

Injection Drug Use and HIV/AIDS: The Canadian HIV/AIDS Legal Network Reacts to Health Canada’s Response to the Network’s 1999 Report on Injection Drug Use and HIV/AIDS

This paper contains: a short summary of the main issues raised in the Network’s 1999 report; a summary of Health Canada’s response to the Network’s report; the Network’s reaction to Health Canada’s response; a short description of next steps the Network will undertake; and suggestions about how to obtain further information.

Injection Drug Use and HIV/AIDS: Health Canada’s Response to the Report of the Canadian HIV/AIDS Legal Network

This document focuses on immediate actions that are being taken to reduce the harm associated with IDU. These initiatives reflect Health Canada’s view that Canada’s response to this urgent health issue requires both improved interventions with individuals who use injection drugs and fundamental changes to the environment in which such interventions are offered.